Vischer, Christoph – Trademark Portfolio
Entity Type: 01
Vischer, Christoph holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ASPAREA. The owner is based in München.
Adams-Lehmann-Str. 71
München 80797 , DE
Showing of trademarks Trademarks
Trademark Classifications
Vischer, Christoph's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Vischer, Christoph have?
Vischer, Christoph has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Vischer, Christoph file in?
Vischer, Christoph files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Vischer, Christoph's most well-known trademarks?
Vischer, Christoph's registered trademark portfolio includes well-known marks such as ASPAREA. These are among 1 currently registered trademark in the portfolio.
What is Vischer, Christoph's trademark registration success rate?
Vischer, Christoph has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.